Azaspiro dihydrotriazines and cycloguanil analogues have been reported as respiratory syncytial virus (RSV) inhibitors targeting the host factor DHFR, suggesting that cellular DHFR activity is essential for the infections caused by RSV [108,109]. This evidence concerns the gene DHFR and infection.